Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission alleges CVS Health’s Caremark Rx, Cigna’s Express Scripts and United Health Group’s OptumRx created a system that prioritizes high rebates from drug manufacturers, leading to artificially high insulin list prices.
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
3don MSN
Kansas City pharmacists walked off the job last September to protest working conditions and brought widespread attention to ...
The method comprises receiving, by a substance management system, a dosage instruction for administering a substance to an ...
When the COVID-19 pandemic put these stores on the front lines of testing and vaccinating patients, it only exacerbated the ...
CVS trades below 9x forward PE, indicating it’s priced for further deterioration, but historically and relatively cheap vs.
CVS retail pharmacy workers across California are carrying out a strike vote that coincides with a powerful strike by 33,000 ...
The new offerings, which started Thursday, aim to make receiving hormonal birth control methods faster, simpler, and more ...
The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially ...
CVS pharmacists in Massachusetts can now prescribe birth control. The new initiative, which was announced Thursday, allows ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback